<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To reclassify retrospectively 370 cases of malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: According to the WHO new classification, the clinical features and pathology as well as immunophenotype of 370 <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were analysed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In the 370 <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, there were 359 non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) (97.03%) and 11 Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) (2.97%) </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 359 NHL, 246 were B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (68.52%), 108 T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (30.08%), 1 each histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and follicular dendritic cell <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, and 3 NK cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were 196 cases (54.6%) and the nodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> 163 cases (45.4%) </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of NHL categories were in proper order as follows: diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (173 cases, 48.2%) &gt; peripheral T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (54 cases, 15.0%) &gt; mucosa associated lymphoid tissue (MALT) <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (31 cases, 8.6%) &gt; NK/T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (25 cases, 7.0%) &gt; follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (21 cases, 5.8%) &gt; anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (12 cases, 3.3%) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The results suggested that the study of malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with WHO new classification have important clinical significance </plain></SENT>
</text></document>